[Research Report] The hypertrophic and keloid scar treatment market was valued at US$ 4,498.99 million in 2019 and is projected to reach US$ 9,972.69 million by 2027; it is expected to grow at a CAGR of 10.6% from 2020 to 2027.
A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.
The scope of the hypertrophic and keloid scar treatment market includes scar type, product type, end user, and region. The market for hypertrophic and keloid scar treatment, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the hypertrophic and keloid scar treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across all the regions. It is estimated that the market is likely to grow at a slower rate in the following years due to the lockdown situations in various countries that have restricted the supply chain of different non-essential medical products. The pandemic has widely affected the aesthetic industry, which has indirectly prohibited scar treatments.
Lucrative Regions for Hypertrophic and Keloid Scar Treatment Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Advantages of Laser Treatment
Technological advancements have led to the successful use of laser especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching, and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries.
As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. This treatment procedure also proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for laser treatment curing hypertrophic and keloid scars.
Scar Type-Based Insights
Based on scar type, the hypertrophic and keloid scar treatment market is bifurcated into hypertrophic and keloid. The hypertrophic segment held a larger share of the market in 2019, as hypertrophic scars are more common. Moreover, these scars do not grow outside the borders of the original wound and eventually grow smaller. Additionally, the treatment for hypertrophic scars typically requires non-invasive procedures such as gels, creams, and silicone sheets in the course of minor injuries and laser treatments. Thus, the segment is estimated to register a higher CAGR in the market during the forecast period.
Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type – 2019 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product Type-Based Insights
Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
End User-Based Insights
Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hypertrophic and Keloid Scar Treatment Market: Strategic Insights
Market Size Value in US$ 4,498.99 Million in 2019 Market Size Value by US$ 9,972.69 Million by 2027 Growth rate CAGR of 10.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hypertrophic and Keloid Scar Treatment Market: Strategic Insights
| Market Size Value in | US$ 4,498.99 Million in 2019 |
| Market Size Value by | US$ 9,972.69 Million by 2027 |
| Growth rate | CAGR of 10.6% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the hypertrophic and keloid scar treatment market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.
By Scar Type
- Hypertrophic
- Keloid
By Product Type
- Laser Products
- CO2
- Pulse-Dyed
- Other Laser Products
- Topical Products
- Creams
- Gels
- Silicone Sheets
- Other Topical Products
- Injectables
- Other Products
By End User
- Hospitals
- Clinics
- Homecare
By
Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Alliance Pharma plc
- Mölnlycke HEALTH CARE AB.
- Smith & Nephew
- Newmedical Technology Inc.
- Rejûvaskin
- Sonoma Pharmaceuticals, Inc.
- Suneva Medical
- HRA Pharma
- Lumenis
- Perrigo Company plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Scar Type , Product Type , and End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.
The growth of the market is attributed to advantages of laser treatment and increasing incidences of injuries. However, unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.
The costs of the treatments of these scars are much higher, and they may cost US$ 1,000–5,000, or more, per treatment. The cost may also differ from product to product and treatment cycles.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hypertrophic and Keloid Scar Treatment Market – ByScar Type
1.3.2 Global Hypertrophic and Keloid Scar Treatment Market – By Product Type
1.3.3 Global Hypertrophic and Keloid Scar Treatment Market – By End User
1.3.4 Global Hypertrophic and Keloid Scar Treatment Market – By Geography
2. Hypertrophic and Keloid Scar Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hypertrophic and Keloid Scar Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South & Central America– PEST Analysis
4.3 Expert Opinion
5. Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Advantages of Laser Treatment
5.1.2 Increasing Cases of Injuries
5.2 Market Restraints
5.2.1 Unavailability of Universal Treatment Due to High Costs, Side Effects, and Scanty Awareness
5.3 Market Opportunities
5.3.1 Tapping Market in Emerging Regions
5.4 Future Trends
5.4.1 Emerging Treatments Modalities
5.5 Impact Analysis
6. Hypertrophic and Keloid Scar Treatment Market – Global Analysis
6.1 Global Hypertrophic and Keloid Scar Treatment Market Revenue Forecast And Analysis
6.2 Global Hypertrophic and Keloid Scar Treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Hypertrophic and Keloid Scar Treatment Market– By Scar Type
7.1 Overview
7.2 Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)
7.3 Hypertrophic
7.3.1 Overview
7.3.2 Hypertrophic: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
7.4 Keloid
7.4.1 Overview
7.4.2 Keloid: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8. Hypertrophic and Keloid Scar Treatment Market– By Product Type
8.1 Overview
8.2 Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)
8.3 Laser Products
8.3.1 Overview
8.3.2 Laser Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.3.3 CO2 Market
8.3.3.1 Overview
8.3.3.2 CO2 Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.3.4 Pulse-Dyed Market
8.3.4.1 Overview
8.3.4.2 Pulse-Dyed Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.3.5 Other Laser Products Market
8.3.5.1 Overview
8.3.5.2 Other Laser Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.4 Topical Products
8.4.1 Overview
8.4.2 Topical Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.4.3 Creams Market
8.4.3.1 Overview
8.4.3.2 Creams: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.4.4 Gels Market
8.4.4.1 Overview
8.4.4.2 Gels: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.4.5 Silicone SheetsMarket
8.4.5.1 Overview
8.4.5.2 Silicone Sheets: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.4.6 Other Topical Products Market
8.4.6.1 Overview
8.4.6.2 Others Topical Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.5 Injectables
8.5.1 Overview
8.5.2 Injectables: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
8.6 Other Products
8.6.1 Overview
8.6.2 Other Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
9. Hypertrophic and Keloid Scar Treatment Market– By End User
9.1 Overview
9.2 Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
10. Hypertrophic and Keloid Scar Treatment Market – Geographic Analysis
10.1 North America: Hypertrophic and Keloid Scar Treatment Market
10.1.1 Overview
10.1.2 North America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.1.4 North America: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.1.4.1 North America: Laser Products Market, by Type, 2018–2027 (USD Million)
10.1.4.2 North America: Topical Products Market, by Type, 2018–2027 (USD Million)
10.1.5 North America: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.1.6 North America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
10.1.7 US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.1.7.3 US: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.1.7.3.1 US: Laser Products Market, by Type, 2018–2027 (USD Million)
10.1.7.3.2 US: Topical Products Market, by Type, 2018–2027 (USD Million)
10.1.7.4 US: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.1.8 Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.1.8.3.1 Canada: Laser Products Market, by Type, 2018–2027 (USD Million)
10.1.8.3.2 Canada: Topical Products Market, by Type, 2018–2027 (USD Million)
10.1.8.4 Canada: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.1.9 Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.1.9.3 Mexico: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.1.9.3.1 Mexico: Laser Products Market, by Type, 2018–2027 (USD Million)
10.1.9.3.2 Mexico: Topical Products Market, by Type, 2018–2027 (USD Million)
10.1.9.4 Mexico: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2 Europe: Hypertrophic and Keloid Scar Treatment Market
10.2.1 Overview
10.2.2 Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.4 Europe: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.4.1 Europe: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.4.2 Europe: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.5 Europe: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.6 Europe: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.7.3 Germany: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.7.3.1 Germany: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.7.3.2 Germany: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.7.4 Germany: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.8 UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.8.3 UK: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.8.3.1 UK: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.8.3.2 UK: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.8.4 UK: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.9 France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.9.3 France: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.9.3.1 France: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.9.3.2 France: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.9.4 France: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.10 Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.10.3 Spain: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.10.3.1 Spain: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.10.3.2 Spain: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.10.4 Spain: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.11 Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.11.3 Italy: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.11.3.1 Italy: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.11.3.2 Italy: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.11.4 Italy: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.2.12 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.2.12.3 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.2.12.3.1 Rest of Europe: Laser Products Market, by Type, 2018–2027 (USD Million)
10.2.12.3.2 Rest of Europe: Topical Products Market, by Type, 2018–2027 (USD Million)
10.2.12.4 Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market
10.3.1 Overview
10.3.2 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.4.1 Asia Pacific: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.4.2 Asia Pacific: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
10.3.7 Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Japan: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.7.3 Japan: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.7.3.1 Japan: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.7.3.2 Japan: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.7.4 Japan: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.8 China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 China: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.8.3 China: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.8.3.1 China: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.8.3.2 China: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.8.4 China: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.9 India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.9.3 India: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.9.3.1 India: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.9.3.2 India: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.9.4 India: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.10 South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.10.3 South Korea: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.10.3.1 South Korea: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.10.3.2 South Korea: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.10.4 South Korea: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.11 Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.11.3 Australia: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.11.3.1 Australia: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.11.3.2 Australia: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.11.4 Australia: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.3.12 Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.3.12.3 Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.3.12.3.1 Rest of Asia Pacific: Laser Products Market, by Type, 2018–2027 (USD Million)
10.3.12.3.2 Rest of Asia Pacific: Topical Products Market, by Type, 2018–2027 (USD Million)
10.3.12.4 Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.4 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market
10.4.1 Overview
10.4.2 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.4.4.1 Middle East & Africa: Laser Products Market, by Type, 2018–2027 (USD Million)
10.4.4.2 Middle East & Africa: Topical Products Market, by Type, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Type, 2018–2027 (USD Million)
10.4.7.3.1 Saudi Arabia: Laser Products Market, by Type, 2018–2027 (USD Million)
10.4.7.3.2 Saudi Arabia: Topical Products Market, by Type, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.4.8 UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.4.8.3 UAE: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.4.8.3.1 UAE: Laser Products Market, by Type, 2018–2027 (USD Million)
10.4.8.3.2 UAE: Topical Products Market, by Type, 2018–2027 (USD Million)
10.4.8.4 UAE: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.4.9 South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.4.9.3 South Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.4.9.3.1 South Africa: Laser Products Market, by Type, 2018–2027 (USD Million)
10.4.9.3.2 South Africa: Topical Products Market, by Type, 2018–2027 (USD Million)
10.4.9.4 South Africa: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.4.10 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.4.10.3 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.4.10.3.1 Rest of Middle East & Africa: Laser Products Market, by Type, 2018–2027 (USD Million)
10.4.10.3.2 Rest of Middle East & Africa: Topical Products Market, by Type, 2018–2027 (USD Million)
10.4.10.4 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.5 South and Central America: Hypertrophic and Keloid Scar Treatment Market
10.5.1 Overview
10.5.2 South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.5.4 South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.5.4.1 South and Central America: Laser Products Market, by Type, 2018–2027 (USD Million)
10.5.4.2 South and Central America: Topical Products Market, by Type, 2018–2027 (USD Million)
10.5.5 South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.5.6 South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.5.7.3 Brazil: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.5.7.3.1 Brazil: Laser Products Market, by Type, 2018–2027 (USD Million)
10.5.7.3.2 Brazil: Topical Products Market, by Type, 2018–2027 (USD Million)
10.5.7.4 Brazil: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.5.8 Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.5.8.3 Argentina: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.5.8.3.1 Argentina: Laser Products Market, by Type, 2018–2027 (USD Million)
10.5.8.3.2 Argentina: Topical Products Market, by Type, 2018–2027 (USD Million)
10.5.8.4 Argentina: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
10.5.9 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)
10.5.9.3 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)
10.5.9.3.1 Rest of South and Central America: Laser Products Market, by Type, 2018–2027 (USD Million)
10.5.9.3.2 Rest of South and Central America: Topical Products Market, by Type, 2018–2027 (USD Million)
10.5.9.4 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Hypertrophic and Keloid Scar Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Hypertrophic and Keloid Scar Treatment Market–Industry Landscape
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 Alliance Pharma PLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Mölnlycke Health Care AB.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Smith & Nephew
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Newmedical Technology Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Rejûvaskin
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sonoma Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Suneva Medical
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 HRA Pharma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lumenis
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Perrigo Company plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Hypertrophic and keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. US: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. US: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Europe: Hypertrophic and keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Europe: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. Europe: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Europe: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Germany: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Germany: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Germany: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Germany: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 32. UK: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 33. UK: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 34. UK: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. UK: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 36. France: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 37. France: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 38. France: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. France: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. France: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Spain: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Spain: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Spain: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Spain: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 45. Spain: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 46. Italy: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 47. Italy: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 48. Italy: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 49. Italy: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Italy: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 51. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 52. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of Europe: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of Europe: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 55. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 56. Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 57. Asia Pacific: Hypertrophic and keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 58. Asia Pacific: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. Asia Pacific: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 60. Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 61. Japan: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 62. Japan: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 63. Japan: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 64. Japan: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 65. Japan: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 66. China: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 67. China: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 68. China: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 69. China: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 70. China: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 71. India: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 72. India: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 73. India: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 74. India: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 75. India: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. South Korea: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 77. South Korea: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 78. South Korea: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 79. South Korea: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 80. South Korea: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 81. Australia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 82. Australia: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 83. Australia: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 84. Australia: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 85. Australia: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 86. Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 87. Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 88. Rest of Asia Pacific: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 89. Rest of Asia Pacific: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 90. Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 91. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 92. Middle East & Africa: Hypertrophic and keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 93. Middle East & Africa: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 94. Middle East & Africa: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 95. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 96. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 97. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 98. Saudi Arabia: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 99. Saudi Arabia: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 100. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 101. UAE: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 102. UAE: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 103. UAE: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 104. UAE: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 105. UAE: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 106. South Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 107. South Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 108. South Africa: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 109. South Africa: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 110. South Africa: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 111. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 112. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 113. Rest of Middle East & Africa: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 114. Rest of Middle East & Africa: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 115. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 116. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 117. South and Central America Hypertrophic and keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 118. South and Central America Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 119. South and Central America Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 120. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 121. Brazil: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 122. Brazil: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 123. Brazil: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 124. Brazil: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 125. Brazil: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 126. Argentina: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 127. Argentina: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 128. Argentina: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 129. Argentina: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 130. Argentina: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 131. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)
Table 132. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 133. Rest of South and Central America: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 134. Rest of South and Central America: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 135. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 136. organic Developments Done By Companies
Table 137. Inorganic Developments Done By Companies
Table 138. Glossary of Terms, Hypertrophic and Keloid Scar Treatment Market
LIST OF FIGURES
Figure 1. Hypertrophic and Keloid Scar Treatment Market Segmentation
Figure 2. Hypertrophic and Keloid Scar Treatment Market, By Region
Figure 3. Global Hypertrophic and Keloid Scar Treatment Market Overview
Figure 4. Hypertrophic Segment Held Largest Share of Scar Type Segment In Hypertrophic and Keloid Scar Treatment Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Hypertrophic and Keloid Scar Treatment Market, By Geography (USD Million)
Figure 7. Global Hypertrophic and Keloid Scar Treatment Market- Leading Country Markets (USD Million)
Figure 8. Global Hypertrophic and Keloid Scar Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint
Figure 16. Global Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast And Analysis – 2019- 2027
Figure 17. Global Hypertrophic and Keloid Scar Treatment Market – By Geography Forecast and Analysis – 2019- 2027
Figure 18. Global Hypertrophic and Keloid Scar Treatment Market – By Geography Forecast and Analysis – 2019 - 2027
Figure 19. Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)
Figure 20. Hypertrophic: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 21. Keloid: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 22. Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)
Figure 23. Laser Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 24. CO2 Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 25. Pulse-Dyed Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 26. Other Laser Products Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 27. Topical Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 28. Creams Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 29. Gels Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 30. Silicone Sheets Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 31. Other Topical Products Market: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 32. Injectables: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 33. Other Products: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 34. Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)
Figure 35. Hospitals: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 36. Clinics: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 37. Homecare: Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)
Figure 38. North America: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 39. North America Hypertrophic and Keloid Scar Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 40. North America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
Figure 41. US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Europe: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 45. Europe: Hypertrophic and Keloid Scar Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 46. Europe: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
Figure 47. Germany: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. UK: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. France: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Spain: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Italy: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Rest of Europe: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 54. Asia Pacific: Hypertrophic and Keloid Scar Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 55. Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
Figure 56. Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 63. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 64. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
Figure 65. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 70. South and Central America Hypertrophic and Keloid Scar Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 71. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)
Figure 72. Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 73. Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 74. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 75. Impact of COVID-19 Pandemic In North American Country Markets
Figure 76. Impact of COVID-19 Pandemic In European Country Markets
Figure 77. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 78. Impact Of COVID-19 Pandemic In Middle East and AfricaMarket
Figure 79. Impact Of COVID-19 Pandemic In South and Central AmericaMarket
Figure 80. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Hypertrophic and Keloid Scar Treatment Market
- Alliance Pharma plc
- Mölnlycke HEALTH CARE AB.
- Smith & Nephew
- Newmedical Technology Inc.
- Rejûvaskin
- Sonoma Pharmaceuticals, Inc.
- Suneva Medical
- HRA Pharma
- Lumenis
- Perrigo Company plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Hypertrophic and Keloid Scar Treatment Market
Jan 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)